The blogger Howard Chang explores the latest advancements bringing hope for a psoriasis cure, some of which were presented at a community event.

Arcutis aims to expand its market reach with new approvals. Management recently pleased the market with its sales guidance ...

A new study published in the Journal of the European Academy of Dermatology and Venereology revealed that subcutaneous ...

Treatment with envudeucitinib was safe and effective through 52 weeks among patients with with moderate to severe plaque psoriasis.

Along with being beneficial for the liver, neem has other surprising health benefits that are based on emerging scientific ...

Prescription Drug User Fee Act (PDUFA) target action date set for June 29, 2026If approved, ZORYVE cream 0.3% would be the first and only topical PDE4 inhibitor indicated for plaque psoriasis in ...

The sNDA was supported by data from a 4 week MUSE study and a long-term open-label study in children aged 2 to 5 years.

SKIMS founder Kim Kardashian shared more insights into her recent brain aneurysm diagnosis and the potential outcome.

A study published in The New England Journal of Medicine has reported that the oral peptide icotrokinra, a selective ...

Biologic therapy use among patients with psoriatic disease was associated with a lower risk for malignancy compared with topical therapy use.

The model is accessible, where patients can attend appointments from home, work, or school, without sacrificing hours to ...

Researchers at Academia Sinica have developed the first population-specific polygenic risk score (PRS) models for people of ...